The development comes at a time when India’s Total Fertility Rate (TFR) has declined to 1.9, below the replacement level of 2.1. In Andhra Pradesh and Telangana, the numbers are even lower at 1.7 and 1.8. The urgency for equitable fertility care, especially for male-factor infertility, has never been greater.
“High levels of DNA fragmentation are associated with 20 to 25% higher miscarriage rates, lower birth weights, and an increased risk of preterm birth. In unexplained recurrent pregnancy loss, up to 25 to 30% of men show elevated DFI,” said Dr. Jyothi C Budi, Medical Director, Ferty9. “With this advanced technology, we can analyse thousands of sperm cells in minutes, assess DNA integrity accurately, and make more informed treatment choices. This helps us select better-quality sperm, improve embryo development, and increase the likelihood of successful outcomes of fertility treatments.”
While poor sperm quality is a key factor in male infertility, traditional testing often overlooks DNA damage that lies beneath the surface. Even sperm that appear normal under a microscope may carry fragmented DNA, impacting fertilization and embryo viability. Manual testing methods also suffer from human error and limited scope.
On World IVF Day, Ferty9 Fertility Centre marked a major leap in fertility care by unveiling the LensHooke X12 PRO, an AI-powered semen analyser, at a special event in Secunderabad. With this, it becomes the first IVF chain in Andhra Pradesh and Telangana to implement the technology across all its centers, reinforcing its commitment to precision diagnostics and inclusive reproductive care.
Related News
The milestone was celebrated at Ferty9’s Secunderabad centre in the presence of popular actress Ms. Laya, whose appearance added a heartfelt note to the occasion. Couples who had successfully conceived and delivered through Ferty9 also joined the celebration, sharing powerful stories of resilience and renewed hope. A symbolic cake-cutting ceremony captured the spirit of the “TogetherinIVF” campaign.
